Home>>Pulmonary vasodilator therapy in the NICU: inhaled nitric oxide, sildenafil, and other pulmonary vasodilating agents.

Search

About

Authors:
Address: Department of Pediatrics, Children's Memorial Hospital, Northwestern University, Chicago, IL 60614, USA. n-porta@northwestern.edu
Journal:

Publication:

abstract

the perinatal transition from fetal to extrauterine life requires a dramatic change in the circulatory pattern as the organ of gas exchange switches from the placenta to the lungs. pulmonary hypertension can occur during early newborn life, and present as early respiratory failure or as a complication of more chronic diseases, such as bronchopulmonary dysplasia. The most effective pharmacotherapeutic strategies for infants with persistent pulmonary hypertension of the newborn are directed at selective reduction of pulmonary vascular resistance. This article discusses currently available therapies for pulmonary hypertension, their biologic rationales, and evidence for their clinical effectiveness.

Related Articles
Review Pharmacologic therapy of persistent pulmonary hypertension of the newborn.
Pharmacol Ther. 2001
Review Pharmacologic therapy of persistent pulmonary hypertension of the newborn.
Weinberger B, Weiss K, Heck DE, Laskin DL, Laskin JD. Pharmacol Ther. 2001 Jan; 89(1):67-79.
Review [Inhaled nitric oxide: a physiologic treatment of persistent pulmonary arterial hypertension in the newborn].
Arch Pediatr. 1997
Review [Inhaled nitric oxide: a physiologic treatment of persistent pulmonary arterial hypertension in the newborn].
Thébaud B, Mercier JC. Arch Pediatr. 1997 Oct; 4(10):988-1003.
Outcome of oral sildenafil therapy on persistent pulmonary hypertension of the newborn at Queen Sirikit National Institute of Child Health.
J Med Assoc Thai. 2011
Outcome of oral sildenafil therapy on persistent pulmonary hypertension of the newborn at Queen Sirikit National Institute of Child Health.
Khorana M, Yookaseam T, Layangool T, Kanjanapattanakul W, Paradeevisut H. J Med Assoc Thai. 2011 Aug; 94 Suppl 3:S64-73.
Review Inhaled nitric oxide for respiratory failure in preterm infants.
Cochrane Database Syst Rev. 2001
Review Inhaled nitric oxide for respiratory failure in preterm infants.
Barrington KJ, Finer NN. Cochrane Database Syst Rev. 2001; (4):CD000509.
Review Inhaled nitric oxide for respiratory failure in preterm infants.
Cochrane Database Syst Rev. 2001
Review Inhaled nitric oxide for respiratory failure in preterm infants.
Barrington KJ, Finer NN. Cochrane Database Syst Rev. 2001; (3):CD000509.